Safety and Efficacy of Prosopis juliflora Leaf Extract as a Potential Treatment against Visceral Leishmaniasis in Balb/c Mice
,
Abstract
Background: Visceral Leishmaniasis caused by Leishmania donovani is a major health problem in the tropics and sub-tropic regions where it is endemic. We aimed in testing the leishmanicidal activity and toxicity of Prosopis juliflora leaf extract in BALB/c mice and in vitro test systems respectively.
Methods: In the year 2017 until 2019, BALB/c mice of mixed sexes aged between 6 and 8 weeks in groups of 8 were used. Group I treated with 100 mg/kg of P. juliflora extract, Group II -1 mg/kg of Sodium stibogluconate (SSG) and Group III treated with normal saline. All mice were anaesthized and sacrificed to obtain blood, spleen samples for antibody measurements, and determination of parasite loads.
Results: There was significant inhibitory effect (P<0.05) exhibited by P. juliflora leaf extract on promastigote growth during the in vitro test whereby up to 98% parasites were killed at the highest concentrations of 100 µg/Ml of the extract as compared to SSG, which showed less inhibitory effect on promastigotes. P. juliflora exhibited a higher splenic antiamastigote effect after 21 days of administration as compared to SSG. P. juliflora methanolic leaf extract induced a higher total IgG level as compared to the reference drug which could be attributed to higher titer in IgG2a subtype in mice treated with the extract, which was not induced in mice, treated with SSG.
Conclusion: P. juliflora exhibited higher inhibitory effects against L. donovani promastigotes as well as amastigotes and induced significantly higher IgG antibody levels as compared to SSG (P<0.05). Furthermore, it was safer than SSG on Vero E6 cells.
2. World Health Organization (WHO). Vis-ceral leishmaniasis: Control strategies and epidemiological situation update in East Africa Report 2015.
3. Diro E, Lynen L, Mohammed R et al. High parasitological failure rate of visceral leishmaniasis to sodium stibogluconate among HIV co-infected adults in Ethiopia. PLoS Neg Trop Dis. 2014; (8): 2875.
4. Singh O, Singh B, Chakravarty J, et al. Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective. Infect Dis Poverty J. 2016; 8(5):19.
5. Oryan A. Plant-derived compounds in treatment of leishmaniasis. Iran J Vet Res. 2015; 1-19.
6. Vadhana P, Singh B, Bharadwaj M et al. Emergence of Herbal Antimicrobial Drug Resistance in Clinical Bacterial Isolates. J Pharm Anal Acta. 2015; 6: 434.
7. Wamburu W, Kareru G, Mbaria M et al. Acute and Sub-Acute Toxicological Eval-uation of Ethanolic Leaves Extract of Prosopis juliflora(Fabaceae). J Nat sci Res. 2013; 3:8-15.
8. Mutiso, Macharia C, Barasa M et al. In vitro and in vivo antileishmanial efficacy of a combination therapy of diminazene and artesunate against Leishmania donovani in BALB/c mice. Rev Inst Med Trop Sao Paulo. 2011; 53(3): 129-32.
9. Beery K, Zucker I. Sex bias in neurosci-ence and biomedical research. Neurosci Biobehav J. 2012 35(3):565-72.
10. Mutiso M, Macharia C, Taracha E, et al. Leishmania donovani whole cell antigen deliv-ered with adjuvants protects against leish-maniasis in vervet monkeys. J Biomed Res. 2012; 26:8-16.
11. Sadeghi-Nejad B, Saki J, Khademvatan S et al. In vitro antileishmanial activity of the Medicinal plant Satureja khuzestanica jamzad. J Med Plant Res. 2011 5(24)
12. Mwololo MS, Mutiso MJ, Macharia CJ et al. In vitro activity and in vivo efficacy of a combination therapy of diminazene and chloroquine against murine visceral leish-maniasis. J Biomed Res. 2015; 29(3):214-23.
13. Ali S, Shoab M, Shafi U et al. Scientific investigation of crude alkaloids from me-dicinal plants for management of diseases, BMC Complement Altern Med. 2016; 16,178.
14. Kipyegon C, Helen K, Patrick K, et al. Ovicidal activity of encapsulated ethanolic extract of Prosopis juliflora Against Haemon-chus contorts Eggs. Int J Pharm Pharm Sci. 2015; 18-22
15. Cos P, Vlietinck AJ, Berghe DV, et al. An-ti-infective potential of natural products: How to develop a stronger in vitro 'proof-of-concept'. J Ethnopharmacol. 2006; (106) 290-302.
16. Hughes J, Silva V, Souza C, et al. Cytotoxi-city effect of alkaloidal extract from Prosopis juliflora Sw. D.C. (Algaroba) pods on glial cells. Braz J Vet Res Anim Sci. 2006; 43. 50-58.
17. Abdullah I, Farooq A, Shazia R et al. Composition, antioxidant and chemother-apeutic properties of the essential oils from two Origanum species growing in Pakistan. Braz J Pharm. 2011; 21:943–952.
18. Sachdeva H, Sehgal R, Kaur S. Tinospora cordifolia as a protective and immunomodu-latory agent incombination with cisplatin against murine visceral leishmaniasis. Exp Parasitol. 2014 ;137: 53-65.
19. Gamboa-Leon R, Vera-Ku M, Peraza-Sanchez R et al. Antileishmanial activity of a mixture of Tridax procumbens and Allium sativum in mice. Parasitol. 2014 ;21: 15.
20. Al-Musayeib N, Ramzi A, Mothan S, et al. Study of the in Vitro Antiplasmodial, An-tileishmanial and Antitrypanosomal Activi-ties of Medicinal Plants from Saudi Arabia. Molecules. 2012;17(10): 11379–11390.
21. Santhaseelan H, Prabha S, Arthur R, et al. Corrigendum to "Biopharmaceutical po-tentials of Prosopis spp. (Mimosaceae, Le-guminosa)" [J Food Drug Anal 25 (2017) 187-196]. J Food Drug Anal. 2017; 25(3):748-749.
22. Heidari M, Badirzadeh A, Khadir F et al. Herbal drugs with promising antileishma-nial activity. New hope for Leishmaniasis treatment. J Skin Stem Cell. 2016;3(2):66527.
23. Mutiso M, Macharia C, Kiio N et al. De-velopment of Leishmania vaccines: predict-ing the future from past and present expe-rience. J Biomed Res. 2013; 27: 85-102.
24. Rostamian M, Bahrami F, Niknam H. Vaccination with whole-cell killed or re-combinant leishmanial protein and toll-like receptor agonists against Leishmania tropica in BALB/c mice. PLoS One. 2018;13(9): 0204491.
| Files | ||
| Issue | Vol 16 No 4 (2021) | |
| Section | Original Article(s) | |
| DOI | https://doi.org/10.18502/ijpa.v16i4.7878 | |
| Keywords | ||
| Prosopis juliflora Sodium stiboglu-conate Balb/c mice Leishmania donovani | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
